Imaging end points for monitoring neurop
β
David J. Brooks
π
Article
π
2003
π
John Wiley and Sons
π
English
β 312 KB
π 2 views
In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is consi